8 Predictions on how Ultrasound Systems Market will Expand through 2022

Due to the increasing adoption of advanced imaging systems in healthcare industry, ultrasound systems continue to be an irreplaceable commodity. In the view of rising healthcare costs, affordable and accurate imaging & diagnosis achieved through ultrasound technology will continue to attract patients, and render profits even in conventional medical settings. Fact.MR’s report on the global market for ultrasound systems projects a steady growth for the market during 2017-2022. The global ultrasound systems market, which is pegged to reach US$ 6 Bn by 2017-end, will soar steadily at a 5.5% CAGR to reach US$ 7.8 Bn towards the end of 2022.

Following are key projections on the global ultrasound systems market, excerpted from the report:

  1. The report highlights the application of ultrasound systems in cardiology. Alarming rise in incidence of cardiac disorders throughout the globe is expected to drive the adoption of ultrasound systems, which are effectively used in cardiology diagnostics. Between 2017 and 2022, more than US$ 430 Mn worth of incremental opportunity will be created by application of ultrasound systems in cardiology. The report also predicts that nearly half of ultrasound systems sold in the global market during the forecast period will be developed on 2D ultrasound imaging technology.
  2. Healthcare infrastructure in developed economies such as the US and Canada is expected to promote the adoption of ultrasound systems. The report projects that by the end of 2022, North America’s ultrasound systems market will have reached an estimated value of US$ 3.2 Bn. During this forecast period, North America is also anticipated to be the largest market for ultrasound systems in the world.
  3. The report also observes impressive growth in the ultrasound systems market across European countries. In 2017, more than 25% of the global ultrasound systems market value is expected to be accounted by sales of ultrasound systems in Europe.
  4. Demand for ultrasound systems in the Asia-Pacific excluding Japan (APEJ) region is projected to be lower than above regions, however, manufacturers will be interested in laying down their production units in this region. In such manner, the APEJ ultrasound systems market is likely to account for more than 15% of the global market revenues throughout the forecast period.
  5. Based on the portability of ultrasound systems, the report expects a higher demand for standalone systems. By procuring revenues worth US$ 4.2 Bn, standalone ultrasound systems will dominate the global market with more than 70% revenue share towards the end of 2017. On the other hand, portable ultrasound systems will showcase a robust revenue growth at 6.4% CAGR, albeit, reflecting a little over 17% share on the global ultrasound systems market.
  6. Hospitals will remain the largest end-users of ultrasound systems in the global market, and account for half of its value in the years to come. Meanwhile, diagnostic centers will contribute to nearly 20% of the global ultrasound systems market, procuring revenues worth US$ 1.6 Bn by 2022-end.

The report has profiled leading players in the global ultrasound systems market, which include companies namely, General Electric Company, Koninklijke Philips N.V., Toshiba Corporation, Siemens AG, Hitachi Ltd., Fujifilm Holdings Corporation, Esaote SpA., Shimadzu Corporation, Analogic Corporation, and Samsung Electronics Co. Ltd.

About Fact.MR       
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

7 Key Projections on Expansion of Syringes Market through 2022

Going forward, a majority of medical procedures in the global healthcare industry will be performed through invasive techniques. The demand for syringes will continue to prevail in the years to come, urging syringe manufacturers remain optimistic. Pivotal importance of syringes as a product in the surgicals industries is expected to remain intact. Fact.MR projects that in 2017, more than US$ 11.3 Bn will be spend by patients, hospitals and other end-users for buying syringes.

In addition to this, rising demand for multifunctional syringes will also shape the dynamics of global syringes market in the future. By the end of 2022, the global market for syringes will have expanded at a robust CAGR of 7.8%, recording an estimated revenues of US$ 16.5 Bn. Following insights are excerpted from this report, which offers key projections on the growth of global syringes market during 2017-2022.

  1. Firstly, the report highlights that North America and the Asia-Pacific excluding Japan (APEJ) regions will be at the forefront of global syringes market expansion. The APEJ syringes market will witness highest growth, bringing in revenues over US$ 5.7 Bn by 2022-end.
  2. Active reforms in the healthcare infrastructure across the US and Canada are likely to remain profitable for syringes market. In 2017, more than US$ 2.5 Bn worth of syringes will be sold in North America, which will soar vigorously through the forecast period to reflect 8.5% CAGR.
  3. Japan, on the other hand, is expected to showcase a sluggish revenue growth for its syringes market, exhibiting a CAGR of 4.3%. The report also projects that Europe’s syringe sales will rise steadily, raking over US$ 4 Bn by the end of 2022.
  4. With increasing complexity in medical & surgical procedures, the demand for specialized syringes is expected to remain higher than that of general syringes. The report expects that a little less than 30% of the global syringes market value will be attained by the sales of specialized syringes. Nevertheless, this contribution will remain dominant compared to general syringes, the sales of which are likely to amass revenues over US$ 3.5 Bn by the end of forecast period.
  5. Over 80% of syringes sold in the global market over the forecast period will be disposable. With that said, the demand for reusable syringes will not be listless, as revenues from global sales of such syringes will reflect a steady growth at 6% CAGR.
  6. The report also highlights that over two-third volume of syringes expected to be sold in the world will be accounted by hospitals. While hospitals will be the largest end-users for syringes, the report also projects that 99.4% of the global syringes market revenues will be arising from sales of polymer syringes through 2022.

According to the report, the companies that are anticipated to remain active in the expansion of global syringes market through 2022 include Becton, Dickinson and Company, B. Braun Melsungen AG, Gerresheimer AG, Hindustan Syringes & Medical Devices Limited, Terumo Corporation, Nipro Corporation, Schott AG, Medtronic PLC, Smiths Group plc., and Codan Medizinische Geräte GmbH & Co Kg.

About Fact.MR       
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

5 Key Takeaways from Fact.MR’s Report on Prostate Cancer Diagnostics Market

According to the latest report by Fact.MR, the global prostate cancer diagnostics market is anticipated to exhibit a steady expansion at 5.3% CAGR during the forecast period 2017 to 2022. In terms of revenues, the market is projected to reach US$ 823.5 Mn in 2017; by 2022 this number is projected to surpass US$ 1,000 Mn.

Diagnosis of prostate cancer is becoming a critical undertaking for medical organizations. Newer treatments on prostate cancer are being developed by considering the scope of diagnostic approach. This emergence of diagnosis-associated treatments on prostate cancer is expected to render higher medical efficiency, providing effective outputs at minimal healthcare spending. Through and through, medical organizations are scanning key criteria associated with diagnosis of prostate cancer, tracking parameters such as age of the patient, ethnicity, family medical history, and diet. Considering the sensitivity of organs in the prostate area, patients are also adopting non-invasive diagnosis tests, which is ultimately impacting the products sold in the global market for prostate cancer diagnostics.

Advancements in technology for finding newer techniques for treatment & diagnostics of prostate cancer, changing lifestyles of people across the globe, and the rise in funding from both private as well as public sector in the development of drugs are some factors influencing growth of the global market for prostate cancer diagnostics. Serum-based market testing is being widely adopted for prostate cancer diagnostics. In order to enhance the test’s sensitivity, it is being evaluated with several other cancer-specific markers. However, risks related to overtreatment and over-diagnosis of PSA screening is expected to incur challenges to growth of the global prostate cancer diagnostics market. However factors such as, high cost of treatment, surgical-associated risks such as blood clots, strokes, and heart attacks, and surgical side effects such as urinary incontinence & impotence are expected to curb growth of the market over the forecast period.

5 Estimations from Fact.MR’s Report on the Global Prostate Cancer Diagnostics Market

  1. North America will continue to be the most lucrative region in the global prostate cancer diagnostics market, in terms of revenues. The prostate cancer diagnostics market in North America and Europe are expected to exhibit similar CAGRs through 2022.
  2. The market in Asia-Pacific excluding Japan (APEJ) is expected to register the fastest expansion through 2022. In contrast, prostate cancer diagnostics market in Middle East & Africa will continue to register a sluggish expansion during the forecast period.
  3. PSA tests will continue to be the largest adopted tests for diagnosis of prostate cancer across the globe. PSA test segment is projected to register the highest CAGR in the market through 2022.
  4. Hospital-associated labs are expected to remain the largest end-users of prostate cancer diagnostics in the global market, however revenues from prostate cancer diagnostics in hospital-associated labs will register the lowest CAGR in the market through 2022.
  5. In terms of revenues, cancer research institutes are expected to register the highest CAGR in the market through 2022. Independent diagnostics labs will remain the second largest end users of the prostate cancer diagnostics during the forecast period.

The report has also profiled key players in the global market for prostate cancer diagnostics, which include Abbott Laboratories, AstraZeneca plc., Bayer Aktiengesellschaft, Danaher Corporation, Becton, Dickinson and Company, Foundation Medicine, Inc., Cancer Genetics, Inc., Myriad Genetics Inc., Agilent Technologies, and Biocept, Inc.

About Fact.MR       
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

Blood Cancer Diagnostics Market: Top 9 Takeaways

Blood Cancer Diagnostics

Fact.MR, in its recent research, offers market forecast and analysis on the blood cancer diagnostics market for the period, 2017-2022. According to the research, the global blood cancer diagnostics market is projected to grow at 6.4% CAGR through 2022. The key takeaways from Fact.MR’s research report include,

  • By test type, the CBC segment, which is currently valued at nearly US$ 77 million, is projected to grow at nearly 5% CAGR. In the North America blood cancer diagnostics market, these tests will continue to account for a significant share of overall revenues.
  • Owing to highly accurate diagnosis, blood testing will also continue to be a widely used test globally. Fact.MR projects this segment to rake in significant revenues by 2022.
  • On back of recent reports about the accuracy and benefits of using liquid biopsy, this segment is gaining traction globally. Research carried out at Massachusetts General Hospital Cancer Center and Harvard Medical School has shown that liquid biopsy can help patients with advanced cholangiocarcinoma. Fact.MR projects this segment to grow at a high CAGR through 2022.
  • The bone marrow test type is also being widely used by end-users owing to its efficacy in diagnosis and management. According to Fact.MR’s analysis, the bone marrow test type is anticipated to rake in significant revenues during the forecast period. Revenues from this segment are anticipated to grow at a healthy CAGR through 2022.
  • Hospital associated labs account for a significant revenue share of the overall demand for blood cancer diagnostics. According to Fact.MR’s analysis, this end-use segment is projected to grow at over 6% CAGR through 2022.
  • Independent diagnostic laboratories are also a major end-user of blood cancer diagnostics. Fact.MR estimates revenues from this segment to grow at over 6% CAGR through 2022. Demand is also anticipated to be strong from the cancer research institutes segment.
  • The blood cancer diagnostics market in the U.S. will continue to account for a significant share of the global revenues. The U.S. will also remain significant owing to R&D and new developments in diagnostics. Fact.MR projects the U.S. blood cancer diagnostics market to account for leading revenue share of the global market.
  • In Europe, Germany and U.K. will account for significant revenue share of the global revenues. Advancements in R&D, combined with increasing prevalence of the disease will hamper growth of the market.
  • Leading companies in the market are focusing on investing in R&D to come up with innovative and accurate diagnostics solutions. Mergers and acquisitions, and collaborations will continue to remain a trend in this market.

The report has also profiled key players in the global market for blood cancer diagnostics, which include companies such as Abbott Laboratories, Thermo Fisher Scientific Inc., Roche Holding A.G., Laboratory Corporation of America Holdings, Luminex Corporation, NanoString Technologies Inc, Myriad Genetics Inc., NeoGenomics Laboratories, Inc., Quest Diagnostics Incorporated, Siemens AG, Qiagen N.V., Biotheranostics, Inc, Agilent Technologies, Almac Group Limited, and GeneNews Limited.

Check Discount- https://www.factmr.com/connectus/sample?flag=D&rep_id=47

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

5 Key Forecasts on Growth of Bone Growth Stimulator Market through 2022

Bone Growth Stimulator

As patients of spinal cord fractures continue to struggle with long duration consumed for complete recovery, surgeons and doctors continue to promote the use of bone growth stimulators. The Fact.MR forecast report on global bone growth stimulator market anticipates that global sales of these devices will bring in more than US$ 1.4 Bn by the end of 2017. Spinal fracture patients opting for bone growth stimulators is expected to rise due to increasing advancements in lowering patient discomfort. By the end of 2022, sales of bone growth stimulators in the global market is pegged to bring in US$ 1.91 Bn, exhibiting a steady growth at 5.3% CAGR.

Key Forecast Highlights

  1. According to the report, bone growth stimulation devices will account for nearly 56% share on global bone growth stimulator revenues in 2017. Platelet-rich plasmas, on the other hand, will be observed as promising product segment, revenues from which are expected to showcase robust growth at 6.2% CAGR. By the end of 2022, a little over US$ 450 Mn worth of platelet-rich plasmas will be sold in the global market for bone growth stimulators.
  2. In the view of poor road infrastructure and inferior healthcare facilities existing in the Asia-Pacific excluding Japan (APEJ) region, the demand for bone growth stimulators is expected to gain grounds. These factors are boosting the incidence of spinal fractures in this region, compelling doctors towards adoption of bone growth simulation therapy. Moreover, manufacturers of bone growth stimulators are expected to benefit from low wage costs and high resource availability by setting up their manufacturing units across APEJ region. By the end of 2022, over US$ 225 Mn worth of bone growth stimulators will be sold across the APEJ market.
  3. North America is expected to remain the largest market for bone growth stimulator. The report predicts that high healthcare spending implemented in Canada and the US will urge manufacturers towards developing advanced bone growth stimulators. Meanwhile, revenues amassed from sales of bone growth stimulators in Europe will contribute US$ 600 Mn in revenues by the end of 2022. Towards the end of forecast period, North America’s bone growth stimulator market is likely to soar at a CAGR of 6.2%.
  4. Application of bone growth stimulators in delayed union & non-union bone fracture treatments is expected to gain traction, reflecting a revenue growth at 5.7% CAGR. Spinal fusion surgeries will account for nearly 25% of the global bone growth stimulator sales in 2017, while their application in oral and maxillofacial surgeries will procure around US$ 250 Mn in global revenues.
  5. Hospitals and clinics are expected to remain largest end-users of bone growth stimulator throughout the forecast period. With more than 43% share, over US$ 800 Mn worth of bone growth stimulators will be sold in hospitals & clinics across the globe by 2022-end. Home care end-use of bone growth stimulator, on the other hand, is expected to create an incremental opportunity of more than US$ 100 Mn by 2022 over 2017.

The report has also profiled leading players in the global bone growth stimulator market, which include companies such as Orthofix International N.V., Medtronic plc, Zimmer Biomet Holdings, Inc., Bioventus Inc., Stryker Corporation, Johnson & Johnson, Arthrex, Inc., DJO Global Inc., Elizur Corporation, and Ossatec Benelux B.V.

Check Discount- https://www.factmr.com/connectus/sample?flag=D&rep_id=54

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

Melanoma Cancer Diagnostics Market:8 Key Takeaways

Melanoma Cancer Diagnostics

According to a latest market research by fast-growing market research and consulting firm, the global melanoma cancer diagnostics market is poised to grow at over 7% CAGR and surpass US$ 853.5 million in revenues by 2022. Fact.MR’s report forecasts that North America and Europe will remain the most lucrative markets for melanoma cancer diagnostics market globally. Key takeaways from Fact.MR’s report are,

  • The U.S. melanoma cancer diagnostics market will grow at over 7% CAGR and reach US$ 409.2 Mn by 2022. By test type, BRAF mutation segment will continue to be the leading segment.
  • Germany is one of the largest markets for melanoma cancer diagnostics in Europe. Fact.MR projects the Germany melanoma cancer diagnostics market to grow at 7.4% CAGR through 2022. Hospital associated labs are the largest end-users of melanoma cancer diagnostics in Germany. The market in United Kingdom will grow at a higher rate than Germany, but it will be continue to be smaller in market size.
  • The market will be positive influenced by increasing R&D on cancer diagnosis and management. Increasing prevalence of melanoma and effective immunotherapies are expected to drive growth of the market globally.
  • Although the outlook on the global melanoma cancer diagnostics market is positive, limited funds in emerging countries, combined with challenges surrounding regulatory issues can stymie growth during the forecast period.
  • By test type, BRAF mutation segment will account for a significant share of global revenues. This test type will continue to be used widely in major markets of North America and Europe. The CTC segment, on the other hand, is projected to grow at a higher CAGR than BRAF segment. Immunohistochemistry, another test type, is projected to grow at over 6% CAGR in the global melanoma cancer diagnostics market.
  • The key end-use segments of the global melanoma cancer diagnostics market have been identified as hospital associated labs, cancer research institutes, and independent diagnostic laboratories. Among these, the hospital associated labs end-use segment is the most prominent globally. According to Fact.MR’s research, hospital associated labs will remain the largest end-users for melanoma cancer diagnostics market during the forecast period.
  • Demand is also expected to remain steady from independent diagnostic laboratories segment. In North America, demand from this segment is expected to surpass US$ 100 million by 2022. The trend will also remain strong in Europe, with this segment growing at nearly 8% CAGR during the forecast period.
  • Leading companies profiled in the report include Cancer Genetics, Inc., Myriad Genetics Inc. Abbott Laboratories, Foundation Medicine, Inc., and Pathway Genomics Corporation

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

9 Key Takeaways from Fact.MR’s Report on Kidney Cancer Diagnostics Market

Kidney Cancer Diagnostics

Fact.MR, in its latest research, anticipates the global kidney cancer diagnostics market to witness an impressive expansion at a CAGR of 6.4% over the forecast period 2017 to 2022.

Tremendous transformations have been witnessed over the recent past, in the management and diagnosis of renal cell carcinoma (RCC), or, kidney cancer. Numerous discoveries, trails, and studies have been taken in active surveillance, renal biopsy, as well as minimally-invasive thermal ablation, on the back of surging diagnosis rate of the small renal masses, observed usually among individuals with high morbidity risks, undergoing operative treatment. These factors are expected to fuel growth of the global market for kidney cancer diagnostics.

Older population are most commonly affected by kidney cancer. Diagnosis of old-aged patients makes kidney cancer diagnostics an intricate chapter in the medical books. MRI and CT scan are staple diagnosis procedures in the global market for kidney cancer diagnostics, however, patients are anticipating the emergence of advanced and more effective diagnosis tests. Moreover, this urge to upgrade the diagnostic approach for kidney cancer patients is also resonated by medical organizations as they continue to direct heavy investments in research & developments of new diagnostic procedures. Improvements in early diagnosis tests have translated huge profits for market players, and these companies are also partnering with medical research organizations to develop diagnostic methods that can concurrently lower the maturation pace of tumor between multiples stages of kidney cancer.

9 Estimations from Fact.MR’s Report on the Global Kidney Cancer Diagnostics Market

  1. Based on end-users, the hospital-associated labs will remain preferred in the market for kidney cancer diagnostics, and are expected to account for the largest revenues over the forecast period.
  2. Independent diagnostic laboratories are estimated to remain the second largest end-users in the global market for kidney cancer diagnostics.
  3. Cancer research institutes will register the fastest expansion in the market during the forecast period.
  4. Immunochemistry tests will remain sought-after in the market for kidney cancer diagnostics, and revenues from these tests will account for US$ 351.8 Mn by 2022-end. Among test type, Immunochemistry test is expected to exhibit the highest CAGR through 2022, followed by the complete blood count test.
  5. Urine analysis is anticipated to remain the second most lucrative tests for diagnosis of kidney cancer across the globe.
  6. Revenues from blood chemistry tests related to kidney cancer diagnostics are expected to remain comparatively lower in the market over the forecast period.
  7. North America will continue to account for the largest revenues in the kidney cancer diagnostics market, followed by Europe.
  8. Market for kidney cancer diagnostics in Europe will register a relatively higher CAGR than in North America throughout the forecast period.
  9. Asia Pacific excluding Japan (APEJ) is expected to remain the fastest growing market for kidney cancer diagnostics over the forecast period.

Competition Tracking

The report has also profiled leading players in the global market for kidney cancer diagnostics, which include NeoGenomics Laboratories, Myriad Genetics Inc, NanoString Technologies Inc., Rosetta Genomics, Sysmex Corporation, Illumina, Inc., Roche Holding AG, Quest Diagnostics Incorporated, Thermo Fisher Scientific Inc., and Abbott Laboratories.

Check Discount- https://www.factmr.com/connectus/sample?flag=D&rep_id=56

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

5 Key Insights on Functional Workwear Apparel Market for Forecast Period 2017 – 2026

With the rapid growth in industrial, manufacturing, and service sector, the workforce is also increasing. Hence, increasing number of companies have set the rules in terms of workwear depending on the nature of the business. Manufacturers are offering a specialized set of clothes including basic and protective workwear. Basic workwear is worn across industries such as food, healthcare, defense, hospitality, industrial sector, etc. Whereas, protective workwear consists of protective clothing such as bacterial resistant, fire resistant, water resistant, etc. These type of protective workwear is being largely used across manufacturing units, steel, fire services, mining, pharmaceuticals, etc.

Technological advancements are also leading to the production of smart and high-tech workwear apparel. These clothes are equipped with sensors that help in maintaining body temperature. They are also made using technically advanced fabrics that provides protection against UV rays and harmful radiation. Manufacturers are also focusing on producing light-weight workwear apparel, along with design to make it comfortable and stylish. However, the high cost of functional workwear apparel and lack of awareness about the use of protective workwear are likely to hamper the growth of the market.

According to the latest report by Fact.MR, the global functional workwear apparel market is expected to witness sluggish growth. The market is estimated to increase to 2.6% CAGR during the forecast period 2017-2026. The market is also projected to bring in US$ 749.3 million revenue by the end of 2026. Owing to the rise in industrial and service sector, companies are moving towards providing workwear apparel offering safety, comfortability, thereby enhancing functionality.  Manufacturers are also focusing on providing stylish business formals and casuals as a part of corporate workwear. Following insights show how the global functional workwear apparel market will perform during the forecast period.

5 Forecast Highlights on Global Functional Workwear Apparel Market

  1. Asia Pacific Excluding Japan (APEJ) is expected to emerge as the largest region in the global functional workwear apparel market. Owing to the growth in manufacturing sector, the rise in the new employment opportunities and growth in the service sector are some of the factors driving the functional workwear apparel market in APEJ.
  2. Europe is also expected to witness growth in the functional workwear apparel. Manufacturers are focusing are increasingly investing in the research and development in terms of fabric innovation and using advanced materials, enabling functionalities such as water resistance, durability, and maintaining body temperature.
  3. Uniforms are expected to be one of the top-selling functional workwear apparel during the forecast period 2017-2026. Uniforms are estimated to bring in more than US$ 300 million revenue by the end of 2026.
  4. Compared to the natural fiber, synthetic fiber is expected to account for maximum revenue share by the end of 2017. Synthetic fiber is projected to bring in nearly US$ 600 million revenue by 2026 end.
  5. The service sector is expected to emerge as one of the largest buyers of the functional workwear apparel. By the end of 2026, the service sector is estimated to exceed US$ 300 million revenue.

The report has also profiled leading players in the global market for functional workwear apparel, which will remain active through 2026. These include companies such as V.F. Corporation, Fristads Kansas AB, Aramark, Rentokil Initial Plc., Engelbert Strauss GmbH & Co. KG, Ansell Limited, Carhartt, Inc., Sioen Industries NV, Lakeland Industries, Inc., Delta Plus Group, Duluth Holdings Inc., Superior Uniform Group, Inc., Mascot International A/S, Jonsson Workwear (Pty) Ltd, and Alsico NV.

About Fact.MR       
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

8 Key Takeaways from Fact.MR’s Study on Breast Cancer Diagnostics Market

According to a recent study by Fact.MR, the global breast cancer diagnostics market is projected to register a moderate CAGR of 4.7% during the forecast period 2017 to 2022. The report estimates the market to surpass US$ 2,000 Mn in revenues by 2022-end.

In diagnostic platforms of breast cancer, a number of technological advancements have led towards a robust transformation of the global market for breast cancer diagnostics. The emergence of hybrid diagnostics instruments with the provision of an enhanced accuracy have been witnessed in the market. Advancements such as these have been fuelling growth of the global market for breast cancer diagnostics. Surging cases of breast cancer, coupled with growing older women population are anticipated to create potential growth opportunities for breast cancer diagnostics market across the globe. However, lack of skilled as well as trained personnel is expected to inhibit the demand for breast cancer diagnostics during the forecast period.

The most common type of cancer for women across the globe currently is breast cancer. The number of breast cancer cases is expected to witness a rise, leading towards the requirement for efficient and early breast cancer detection. An established method, mammography, adopted in many countries, has recently been observed to provide inconclusive test results. Personalized and risk-adapted therapy are expected to resolve these difficulties. Tomosythesis, which has emerged as a new imaging technology, promises to overcome the challenges incurred in mammography.

8 Estimations for the Global Breast Cancer Diagnostics Market

  1. By test type, BRCA will remain dominant in the global breast cancer diagnostics market.
  2. CA test for diagnostics of breast cancer is expected to register the highest CAGR through 2022 in the market, followed by ER & PR. Revenue from ER & PR, and CA tests will continue to be low throughout the forecast period.
  3. HER 2 test is expected to remain the second largest segment among test type, in the market. However, EGFR mutation test is estimated to account for low revenues in the global market for breast cancer diagnostics.
  4. North America will continue to be the largest market for breast cancer diagnostics. Revenues from breast cancer diagnostics market in North America is estimated to surpass US$ 800 Mn by 2022-end.
  5. Europe will remain the second most lucrative region for the breast cancer diagnostics market. However, markets in Japan, and Middle East & Africa (MEA) are anticipated to witness a sluggish expansion throughout the forecast period.
  6. Hospital-associated labs will remain sought-after among end-users for breast cancer diagnostics around the world. Revenues from breast cancer diagnostics will remain largest in hospital-associated labs, followed by the independent diagnostic laboratories.
  7. Cancer research institutes are anticipated to exhibit the highest CAGR during the forecast period. Between 2017 and 2022, cancer research institutes are estimated to create absolute $ opportunity of US$ 107.3 Mn.
  8. Key market players mentioned in Fact.MR’s report include Siemens AG, Myriad Genetics, Inc., Roche Holding AG, Illumina, Inc., Epigenomics AG, Abbott Laboratories, Thermo Fischer Scientific, Inc., Bio-Rad Laboratories, Inc., Biocept, Inc., AstraZeneca plc, and Quest Diagnostics Incorporated.

About Fact.MR                                                 
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.

9 Key Takeaways from Fact.MR’s Report on Speech Generating Devices Market

The global speech generating devices market is expected to exhibit a staggering expansion at 12.2% CAGR over the forecast period 2017 to 2022, according to a report by Fact.MR. The report anticipates the market to account for revenues worth US$ 168.6 Mn in 2017, and the market is further estimated to reach nearly US$ 300 Mn by 2022-end.

Various developments in electronic technology have been witnessed over the past decade, rendering the speech generating devices portable and more user interactive. Speech generating devices exist in several variants on the basis of levels of cognitive abilities, physical abilities, symbol system, tongue switches, text, and eye tracking system. Growth of the global speech generating devices market is primarily attributed to increasing availability of user-friendly devices and advancements in technology. According to the National Institute of Deafness & Other Communication Disorders (NIDCD), it is estimated that approximately 7.5 Mn of the U.S. population is affected with some kind of speech related disorders.

Global leaders in speech generating devices market are focusing on enhancement of touch-screen devices for the provision of easy navigation to users. In addition, these manufacturers are providing speech generating devices with the ability to connect with variety of smart phone versions such as iPhone and Android. On the back of speech generating devices’ portable nature, demand for these devices is gaining higher traction among patients with speech impairments. This is further expected to create huge opportunities for manufacturers of speech generating devices. However, factors such as low penetration of speech generating devices, coupled with their high cost are expected to inhibit growth of the market during the forecast period.

Projections for the Global Speech Generating Devices Market

  1. North America will continue to be the most lucrative region for growth of the speech generating devices market, followed by Europe. Revenue from sales of speech generating devices in North America is expected to reach US$ 126.7 Mn by 2022-end.
  2. Sales of speech generating devices in Asia-Pacific excluding Japan (APEJ) will continue to register the fastest expansion during the forecast period.
  3. Synthesized speech devices will remain preferred among products in the market, followed by picture communicators.
  4. Sales of text-to-speech devices are expected to register the highest CAGR in the market through 2022.
  5. On the basis of display, although static display for speech generating devices will remain sought-after in the market, sales of dynamic display will exhibit a comparatively faster expansion throughout the forecast period.
  6. Specialty clinics are expected to remain the largest distribution channel for sales of speech generating devices, expanding at the highest CAGR through 2022.
  7. Hospitals will continue to hold second position in the market based on distribution channel, to account for more than US$ 100 Mn by 2022-end.
  8. By technology, manual speech generating devices will witness largest adoption, followed by head tracking and eye tracking technology-based speech generating devices.
  9. MR’ report profiles key players in the global speech generating devices market, which include Tobii Dynavox, Prentke Romich Company, Inc., Lingraphica, Abilia Toby Churchill Limited, AMDi, Textspeak, Saltillo Corporation, Zyteq Pty Ltd., and Zygo USA.

About Fact.MR                                                 
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Yogesh is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO.